$RGLS
Regulus Therapeutics Inc.

2020 Q1 Form 10-K Financial Statement

#000162828020003483 Filed on March 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2018 Q4 2018 Q3
Revenue $6.000K $18.00K $18.00K
YoY Change -99.91% 0.0% 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.420M $2.750M $2.990M
YoY Change -31.44% -15.64% 9.12%
% of Gross Profit
Research & Development $3.119M $5.260M $6.879M
YoY Change -47.87% -49.76% -45.82%
% of Gross Profit
Depreciation & Amortization $126.0K $590.0K $550.0K
YoY Change -74.9% 1.72% -5.17%
% of Gross Profit
Operating Expenses $5.541M $8.000M $9.872M
YoY Change -41.77% -41.71% -36.03%
Operating Profit -$5.535M -$9.854M
YoY Change 102.15% -36.08%
Interest Expense $489.0K -$520.0K $620.0K
YoY Change -15.4% -35.0% 6.9%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$5.945M -$8.500M -$10.27M
YoY Change 82.36% -41.42% -35.12%
Income Tax -$8.000K $60.00K $0.00
% Of Pretax Income
Net Earnings -$5.937M -$8.563M -$10.27M
YoY Change 82.12% -40.73% -35.1%
Net Earnings / Revenue -98950.0% -47572.22% -57072.22%
Basic Earnings Per Share
Diluted Earnings Per Share -$246.9K -$971.6K -$1.180M
COMMON SHARES
Basic Shares Outstanding 21.04M shares 8.750M shares 104.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.10M $13.90M $20.50M
YoY Change 172.82% -76.87% -71.29%
Cash & Equivalents $28.05M $13.94M $14.08M
Short-Term Investments $0.00 $6.400M
Other Short-Term Assets $955.0K $1.140M $717.0K
YoY Change 19.23% -24.3% -59.08%
Inventory
Prepaid Expenses $3.924M $4.194M $4.194M
Receivables $700.0K $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $33.61M $19.30M $25.44M
YoY Change 89.45% -71.09% -68.03%
LONG-TERM ASSETS
Property, Plant & Equipment $801.0K $7.806M $8.324M
YoY Change -49.87% -19.59% -18.17%
Goodwill
YoY Change
Intangibles $159.0K $500.0K $676.0K
YoY Change -60.93% -35.48% -15.71%
Long-Term Investments
YoY Change
Other Assets $439.0K $326.0K $327.0K
YoY Change 230.08% -44.75% 6.51%
Total Long-Term Assets $1.399M $8.632M $9.327M
YoY Change -34.57% -22.04% -17.32%
TOTAL ASSETS
Total Short-Term Assets $33.61M $19.30M $25.44M
Total Long-Term Assets $1.399M $8.632M $9.327M
Total Assets $35.01M $27.93M $34.77M
YoY Change 76.11% -64.11% -61.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.030M $1.714M $1.235M
YoY Change -61.13% -70.15% -76.38%
Accrued Expenses $860.0K $1.625M $1.856M
YoY Change -50.72% -67.11% -61.09%
Deferred Revenue $0.00 $2.572M $72.00K
YoY Change -100.0% 3472.22%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $14.60M $16.60M $19.10M
YoY Change -5.81% -16.58%
Total Short-Term Liabilities $19.79M $26.65M $25.65M
YoY Change -20.35% -18.26% 118.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $318.0K $309.0K $373.0K
YoY Change -71.25% 6.27%
Total Long-Term Liabilities $318.0K $309.0K $373.0K
YoY Change -71.25% 6.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.79M $26.65M $25.65M
Total Long-Term Liabilities $318.0K $309.0K $373.0K
Total Liabilities $20.10M $33.78M $33.19M
YoY Change -22.52% -20.69% -21.47%
SHAREHOLDERS EQUITY
Retained Earnings -$417.3M -$392.7M -$384.2M
YoY Change 5.37% 13.55% 15.92%
Common Stock $432.2M $386.9M $385.8M
YoY Change 10.83% 1.49% 1.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.90M -$5.854M $1.578M
YoY Change
Total Liabilities & Shareholders Equity $35.01M $27.93M $34.77M
YoY Change 76.11% -64.11% -61.73%

Cashflow Statement

Concept 2020 Q1 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$5.937M -$8.563M -$10.27M
YoY Change 82.12% -40.73% -35.1%
Depreciation, Depletion And Amortization $126.0K $590.0K $550.0K
YoY Change -74.9% 1.72% -5.17%
Cash From Operating Activities -$6.002M -$4.010M -$11.45M
YoY Change 35.39% -63.87% -1.8%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$20.00K
YoY Change -100.0% -80.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $6.440M $12.95M
YoY Change -100.0% 43.75% -154.64%
Cash From Investing Activities $0.00 $6.440M $12.93M
YoY Change -100.0% 46.36% -154.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.000K
YoY Change -99.95%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$67.00K -2.570M -890.0K
YoY Change -110.2% -102.06%
NET CHANGE
Cash From Operating Activities -$6.002M -4.010M -11.45M
Cash From Investing Activities $0.00 6.440M 12.93M
Cash From Financing Activities -$67.00K -2.570M -890.0K
Net Change In Cash -$6.069M -140.0K 590.0K
YoY Change 67.88% -97.91% -92.33%
FREE CASH FLOW
Cash From Operating Activities -$6.002M -$4.010M -$11.45M
Capital Expenditures $0.00 $0.00 -$20.00K
Free Cash Flow -$6.002M -$4.010M -$11.43M
YoY Change -63.61% -1.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 rgls Upfront Payment Received
UpfrontPaymentReceived
2500000 USD
CY2019Q1 rgls Upfront Payment Received
UpfrontPaymentReceived
1800000 USD
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001505512
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21040118 shares
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 dei Entity Public Float
EntityPublicFloat
24300000 USD
CY2019 dei Entity Registrant Name
EntityRegistrantName
REGULUS THERAPEUTICS INC.
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 rgls Accumulated Other Comprehensive Income Loss Unrealized Gainon Short Term Investments
AccumulatedOtherComprehensiveIncomeLossUnrealizedGainonShortTermInvestments
134000 USD
CY2019Q4 rgls Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
CY2019Q4 rgls Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
164000 USD
CY2018Q4 rgls Deferred Tax Assets Property Plant And Equipment And Intangible Assets
DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets
0 USD
CY2019Q4 rgls Deferred Tax Assets Property Plant And Equipment And Intangible Assets
DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets
782000 USD
CY2019 rgls Defined Contribution Minimum Age Requirement Of Eligible Employees
DefinedContributionMinimumAgeRequirementOfEligibleEmployees
P18Y
CY2019 rgls Defined Contribution Plan Employee Contributions Percentageof Eligible Compensation
DefinedContributionPlanEmployeeContributionsPercentageofEligibleCompensation
0.5
CY2018 rgls Effective Income Tax Rate Reconciliation Reservefor Uncertain Tax Positions Amount
EffectiveIncomeTaxRateReconciliationReserveforUncertainTaxPositionsAmount
3596000 USD
CY2019 rgls Effective Income Tax Rate Reconciliation Reservefor Uncertain Tax Positions Amount
EffectiveIncomeTaxRateReconciliationReserveforUncertainTaxPositionsAmount
1444000 USD
CY2019 rgls Financingfrom Sale Proceeds Debt Agreement Revenues
FinancingfromSaleProceedsDebtAgreementRevenues
454100000 USD
CY2018 rgls Gainon Reductionof Lease Liability
GainonReductionofLeaseLiability
0 USD
CY2019 rgls Gainon Reductionof Lease Liability
GainonReductionofLeaseLiability
1839000 USD
CY2019Q1 rgls Lease Expense Extinguished
LeaseExpenseExtinguished
14400000 USD
CY2019Q4 rgls Lease Liabilities
LeaseLiabilities
1111000 USD
CY2019Q4 rgls Lease Right Of Use Asset
LeaseRightOfUseAsset
930000 USD
CY2018Q3 rgls Non Cash Stock Based Compensation Charge
NonCashStockBasedCompensationCharge
100000 USD
CY2018Q4 rgls Numberof Optionholders
NumberofOptionholders
31 optionholder
CY2019 rgls Operatingand Finance Lease Payments
OperatingandFinanceLeasePayments
1043000 USD
CY2018 rgls Paymentson Finance Leases
PaymentsonFinanceLeases
200000 USD
CY2019 rgls Paymentson Finance Leases
PaymentsonFinanceLeases
263000 USD
CY2018 rgls Proceeds From Capital Lease Financing
ProceedsFromCapitalLeaseFinancing
492000 USD
CY2019 rgls Proceeds From Capital Lease Financing
ProceedsFromCapitalLeaseFinancing
0 USD
CY2018Q3 rgls Reductionof Workforce
ReductionofWorkforce
0.60
CY2018Q4 rgls Rent Less Current Portion Liability
RentLessCurrentPortionLiability
6820000 USD
CY2019Q4 rgls Rent Less Current Portion Liability
RentLessCurrentPortionLiability
0 USD
CY2018Q4 rgls Share Based Eligible Exchange Offer Shares
ShareBasedEligibleExchangeOfferShares
915009 shares
CY2019 rgls Stock Issued During Period Shares Preferred Stock Warrants From Private Placement Netof Offering Costs Value
StockIssuedDuringPeriodSharesPreferredStockWarrantsFromPrivatePlacementNetofOfferingCostsValue
40084000 USD
CY2018 rgls Unrecognized Tax Benefits Increases Decreases Resultingfrom Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesDecreasesResultingfromPriorPeriodTaxPositions
5961000 USD
CY2019 rgls Unrecognized Tax Benefits Increases Decreases Resultingfrom Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesDecreasesResultingfromPriorPeriodTaxPositions
-7000 USD
CY2018Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000 USD
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5440000 USD
CY2018Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
26000 USD
CY2019Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1141000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1714000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1321000 USD
CY2018 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-148000 USD
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1625000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
917000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9894000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4410000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
386860000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
431305000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5441000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2288000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2288000 USD
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 USD
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3342533 shares
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2018Q4 us-gaap Assets
Assets
27927000 USD
CY2019Q4 us-gaap Assets
Assets
42081000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
19295000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
40407000 USD
CY2018Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
11173000 USD
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
8909000 USD
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13935000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34121000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13519000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13935000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34121000 USD
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
416000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20186000 USD
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
87640000 shares
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8818019 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21018663 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8818019 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21018663 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
9000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
21000 USD
CY2018Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
77000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2572000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6000 USD
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
6000 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0 USD
CY2018Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
1844000 USD
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-26000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-13000 USD
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-25000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-12000 USD
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000 USD
CY2018Q4 us-gaap Debt Current
DebtCurrent
16575000 USD
CY2019Q4 us-gaap Debt Current
DebtCurrent
14631000 USD
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
87000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
13000 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
87000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
13000 USD
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
16000 USD
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1000 USD
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
115162000 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
115901000 USD
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
114986000 USD
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
115576000 USD
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
26000 USD
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
12000 USD
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
74965000 USD
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
79675000 USD
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2027000 USD
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
461000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
33121000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
33429000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5033000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1389000 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
114960000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
115564000 USD
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2262000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
115600000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
176000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
325000 USD
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 USD
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.50
CY2019 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2300000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
931000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
900000 USD
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.85
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.59
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.18
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.98
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.59
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.08
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1601000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1676000 USD
CY2018 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 USD
CY2019 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 USD
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
5000 USD
CY2019 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
24000 USD
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
333000 USD
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
277000 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
56000 USD
CY2019Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
344000 USD
CY2019Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
287000 USD
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
57000 USD
CY2019Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
11000 USD
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
263000 USD
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
466000 USD
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
182000 USD
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.049
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y2M
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
100000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
100000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
100000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
100000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
100000 USD
CY2019 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P14Y10M25D
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12860000 USD
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11317000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48647000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18591000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 USD
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
12706000 USD
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
603000 USD
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10216000 USD
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3904000 USD
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
251000 USD
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
3934000 USD
CY2018 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-45000 USD
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
46000 USD
CY2018 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
441000 USD
CY2019 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-358000 USD
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-3005000 USD
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1390000 USD
CY2018 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
3666000 USD
CY2019 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
374000 USD
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000 USD
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000 USD
CY2018 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-347000 USD
CY2019 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
1115000 USD
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4029000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-393000 USD
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1370000 USD
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-708000 USD
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2428000 USD
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2572000 USD
CY2018 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-1252000 USD
CY2019 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
0 USD
CY2018 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-384000 USD
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
75000 USD
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-630000 USD
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
242000 USD
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
325000 USD
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1895000 USD
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-134000 USD
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-270000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
500000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
266000 USD
CY2018 us-gaap Interest And Other Income
InterestAndOtherIncome
459000 USD
CY2019 us-gaap Interest And Other Income
InterestAndOtherIncome
374000 USD
CY2018 us-gaap Interest Expense
InterestExpense
2343000 USD
CY2019 us-gaap Interest Expense
InterestExpense
2131000 USD
CY2018 us-gaap Interest Paid Net
InterestPaidNet
2073000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
1655000 USD
CY2019 us-gaap Lease Cost
LeaseCost
902000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
871000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
429000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
442000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
93000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
33781000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
22066000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27927000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42081000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26646000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21598000 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2830000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39933000 USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
46519000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
74000 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43273000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19821000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-16025000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-13847000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-10273000 USD
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-8563000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-48709000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-3260000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-5016000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-5423000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-4893000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-18592000 USD
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
15601000 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
13362000 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
9872000 USD
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
8000000 USD
CY2018 us-gaap Operating Expenses
OperatingExpenses
46835000 USD
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
9516000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
4686000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
5011000 USD
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
4453000 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
23666000 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-46763000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-16834000 USD
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
715000 USD
CY2018 us-gaap Operating Lease Expense
OperatingLeaseExpense
1300000 USD
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
700000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
778000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
361000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
417000 USD
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
756000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
464000 USD
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.109
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2700000 USD
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
3000000 USD
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2900000 USD
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2800000 USD
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2700000 USD
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1000000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
326000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
487000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
221000 USD
CY2018 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2019 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1140000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1221000 USD
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2559000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3047000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
309000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
468000 USD
CY2018 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
756000 USD
CY2019 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
293000 USD
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
4194000 USD
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
3924000 USD
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
23000 USD
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22000 USD
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
219000 USD
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2086000 USD
CY2018 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
CY2019 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
40084000 USD
CY2018 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
46541000 USD
CY2019 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
0 USD
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
318000 USD
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000 USD
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17700000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5331000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7806000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
921000 USD
CY2018 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
3342000 USD
CY2019 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1977000 USD
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33975000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12349000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-392723000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-411315000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-344014000 USD
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18000 USD
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18000 USD
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6778000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6832000 USD
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
778000 USD
CY2018Q3 us-gaap Severance Costs1
SeveranceCosts1
800000 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
5441000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
2288000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3098000 shares
CY2018Q4 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
603058 shares
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
219000 USD
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3000 USD
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2083000 USD
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 USD
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
35216000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-5854000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
20015000 USD
CY2019 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.08333
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4421000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
14700000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16573000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16600000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
4318000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1880000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
13300000 USD
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8718563 shares
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17260176 shares
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:20px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentrations of Credit Risk </font></div><div style="line-height:120%;padding-top:4px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash equivalents and short-term investments. We maintain deposits in federally insured financial institutions in excess of federally insured limits. We have not experienced any material losses in such accounts and believe we are not exposed to significant risk. We maintain our cash equivalents with two highly accredited financial institutions. We have historically invested our excess cash primarily in certificates of deposit and debt instruments of financial institutions and corporations, United States Treasury securities and United States government-sponsored enterprise securities. Additionally, we adhere to established guidelines regarding approved investments and maturities of investments, which are designed to preserve their principal value and maintain liquidity.</font></div></div>
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our financial statements are prepared in accordance with U.S. generally accepted accounting principles ("GAAP"), which requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements and accompanying notes. An estimated loss contingency is accrued in our financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Although these estimates are based on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates and assumptions.</font></div></div>

Files In Submission

Name View Source Status
0001628280-20-003483-index-headers.html Edgar Link pending
0001628280-20-003483-index.html Edgar Link pending
0001628280-20-003483.txt Edgar Link pending
0001628280-20-003483-xbrl.zip Edgar Link pending
a201910kex-231xconsentofin.htm Edgar Link pending
a201910kex-311xcertofprinc.htm Edgar Link pending
a201910kex-312xcertofprinc.htm Edgar Link pending
a201910kex-321xcertpursuan.htm Edgar Link pending
a201910kex-43xdescriptiono.htm Edgar Link pending
bussectionpipelineslidea02.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
rgls-20191231.xml Edgar Link completed
rgls-20191231.xsd Edgar Link pending
rgls-20191231_cal.xml Edgar Link unprocessable
rgls-20191231_def.xml Edgar Link unprocessable
rgls-20191231_lab.xml Edgar Link unprocessable
rgls-20191231_pre.xml Edgar Link unprocessable
rgls20191231-10k.htm Edgar Link pending
Show.js Edgar Link pending